| Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial JFR Robertson, IM Bondarenko, E Trishkina, M Dvorkin, L Panasci, ... The Lancet 388 (10063), 2997-3005, 2016 | 604 | 2016 |
| A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea … M Aapro, H Rugo, G Rossi, G Rizzi, ME Borroni, I Bondarenko, T Sarosiek, ... Annals of oncology 25 (7), 1328-1333, 2014 | 273 | 2014 |
| Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival T Lehnert, S Cardona, U Hinz, F Willeke, G Mechtersheimer, M Treiber, ... European Journal of Surgical Oncology (EJSO) 35 (9), 986-993, 2009 | 182 | 2009 |
| Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas MHM Schwarzbach, U Hinz, A Dimitrakopoulou-Strauss, F Willeke, ... Annals of surgery 241 (2), 286-294, 2005 | 124 | 2005 |
| Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours S Cardona, M Schwarzbach, U Hinz, A Dimitrakopoulou-Strauss, ... European journal of surgical oncology 29 (6), 536-541, 2003 | 107 | 2003 |
| Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? N Fadaki, R Li, B Parrett, G Sanders, S Thummala, L Martineau, ... Annals of surgical oncology 20, 3089-3097, 2013 | 99 | 2013 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 53 | 2023 |
| NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results … M Aapro, M Karthaus, L Schwartzberg, I Bondarenko, T Sarosiek, ... Supportive Care in Cancer 25, 1127-1135, 2017 | 53 | 2017 |
| A new gene expression signature for triple-negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy SK Santuario-Facio, S Cardona-Huerta, YX Perez-Paramo, V Trevino, ... Molecular Medicine 23, 101-111, 2017 | 51 | 2017 |
| Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET). MH Schwarzbach, A Dimitrakopoulou-Strauss, G Mechtersheimer, U Hinz, ... Anticancer research 21 (5), 3609-3614, 2001 | 49 | 2001 |
| Fertility concerns among breast cancer patients in Mexico C Villarreal-Garza, BA Martinez-Cannon, A Platas, A Mohar, AH Partridge, ... The Breast 33, 71-75, 2017 | 34 | 2017 |
| FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole for hormone receptor-positive advanced breast cancer MJ Ellis, I Bondarenko, E Trishkina, M Dvorkin, L Panasci, A Manikhas, ... Annals of Oncology 27, vi554, 2016 | 33 | 2016 |
| Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer JG Tamez-Pena, JA Rodriguez-Rojas, H Gomez-Rueda, ... PloS one 13 (3), e0193871, 2018 | 26 | 2018 |
| Apparent diffusion coefficient (ADC) value to evaluate BI-RADS 4 breast lesions: correlation with pathological findings YA Ramírez-Galván, S Cardona-Huerta, E Ibarra-Fombona, ... Clinical imaging 39 (1), 51-55, 2015 | 26 | 2015 |
| Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib N Fadaki, S Cardona-Huerta, L Martineau, S Thummala, ST Cheng, ... Case Reports 2012, bcr2012007034, 2012 | 23 | 2012 |
| Genetic alterations of triple negative breast cancer (TNBC) in women from Northeastern Mexico GI Uscanga‑Perales, SK Santuario‑Facio, CN Sanchez‑Dominguez, ... Oncology letters 17 (3), 3581-3588, 2019 | 20 | 2019 |
| Immunotyping of tumor‑infiltrating lymphocytes in triple‑negative breast cancer and genetic characterization GS Gomez‑Μacias, G Molinar‑Flores, CA Lopez‑Garcia, ... Oncology letters 20 (5), 1-1, 2020 | 15 | 2020 |
| Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study S Kuemmel, CA Tondini, J Abraham, Z Nowecki, B Itrych, E Hitre, ... Breast Cancer Research and Treatment 187, 467-476, 2021 | 13 | 2021 |
| Initial experience in Mexico with convalescent plasma in COVID-19 patients with severe respiratory failure, a retrospective case series MF Martinez-Resendez, F Castilleja-Leal, A Torres-Quintanilla, ... medRxiv, 2020.07. 14.20144469, 2020 | 12 | 2020 |
| “Joven & Fuerte”: program for young women with breast cancer in Mexico—initial results C Villarreal-Garza, A Castro-Sánchez, A Platas, M Miaja, ... Revista de investigacion Clinica 69 (4), 223-228, 2017 | 12 | 2017 |
